A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

Clinical trial NCT01813227 · COMPLETED

Trial details

NCT number: NCT01813227
Sponsor: Hackensack Meridian Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinemia

Start date: 2013-04-01
Primary completion: 2014-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.